Emad Shash/LinkedIn
Jun 24, 2025, 07:29
Emad Shash: Thrilled to have spent last weekend immersed in CJC 360-Precision Oncology: Deciphering Onco-Code
Emad Shash, Leading Cancer Researcher and Director at National Cancer Institute, Cairo University, shared on LinkedIn:
“Thrilled to have spent last weekend immersed in CJC 360—Precision Oncology: Deciphering Onco-Code.
As moderator for the “Precision Liquid Testing in Oncology” session and speaker on precision-guided breast cancer care, I was energized by the depth of discussion and the spirit of collaboration that ran through every panel and molecular-tumor-board case.Key takeaways:
Tissue vs. liquid profiling: when to deploy each tool for maximum clinical impact
ctDNA in real-time monitoring: moving from promise to practice
AI and big data: accelerating biomarker discovery and clinical-trial matching
Equitable access: strategies to ensure next-generation diagnostics reach every patient
A heartfelt thank-you to the CAIRO Journal Club board, Dynamic, and Pfizer, our industry partner, for crafting a program that places science first and patients at the center. Events like these reaffirm Egypt’s growing leadership in precision medicine and ignite fresh ideas to translate directly to the clinic.
Let’s keep the momentum—and the conversation—going.”
More posts featuring Emad Shash on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20
Jun 26, 2025, 13:31